Previous studies have shown that T cell subpopulations change in the cerebrospinal fluid and blood of AD patients, and peripheral CD4 + T cells can cross the blood–brain barrier, contributing to the pathological formation of AD (Guo et al., 2023). This evidence concerns the gene CD4 and Alzheimer disease.